Ivermectin (IVM) and moxidectin (MXD) are broad-spectrum endectocide antiparasitic drugs extensively used in food-producing animals. The patterns of IVM and MXD excretion in milk were comparatively characterized following their subcutaneous administration (200 microg.kg(-1) of body weight) to lactating dairy sheep. The relationship between milk excretion and plasma disposition kinetics of both compounds was characterized. A pool of milk collected from all of the animals in each experimental group was used for cheese elaboration. IVM and MXD residual concentrations were assessed during the cheese-making process and ripening period. IVM and MXD concentrations were measured in plasma, milk, and milk product (whey, curd, and cheese) samples using an HPLC-based methodology with fluorescence detection. IVM and MXD were extensively distributed from the bloodstream to the mammary gland, and large quantities, particularly of MXD, were excreted in milk. Residual concentrations of both compounds were recovered in milk up to 30 (IVM) and 35 (MXD) days post-treatment. The total fraction of the administered dose excreted in milk for MXD was significantly higher than that of IVM. During cheese production, the highest residual concentrations of both molecules were measured in the curd. Thirty-four percent of the total drug residue measured in the pooled milk collected from treated sheep was lost during the cheese-making process. The lowest residual concentrations were measured in the whey. IVM and MXD concentrations in the elaborated cheese tended to increase during the ripening period, reaching the highest residual level at 40 days of cheese maturation. The long persistence of milk residual concentrations of MXD and IVM in lactating dairy sheep and the high concentrations found in cheese and other milk-related products should be seriously considered before recommendation of the extralabel use of these antiparasitic drugs in dairy animals.

No abstract

Summary :66 Pampinta breed ewes were studied during milking to evaluate the infection and the effect of gastrointestinal nematode on milk production sheep system. Naturally infected ewes on pasture were randomly allocated to two groups: TG, suppressively treated group every four weeks with levamisole and UG, untreated group. Faecal nematode egg counts and larval differentiation were conducted monthly. Successive groups of worm free tracer lambs were grazed with ewes and then slaughtered for worm counts. Test-day milk yield of individual ewes was recorded and ewe machine-milking period length (MPL) were estimated. Faecal egg counts and tracer nematode numbers increased towards midsummer and declined sharply toward the end of the study. TG (188.0 ± 60 liters) produced more (p < 0.066) milk liters than UG (171.9 ± 52.2) and TG had significantly more extended (p < 0.041) MPL than those of UG. The present study showed that dairy sheep were negatively affected by worms, even when exposed to short periods of high acute nematode (mainly Haemonchus contortus) infection.

The relationship between somatic cell counts (SCC) and California mastitis test (CMT) results according to the infectious status of mammary halves and parity of Pampinta dairy ewes was evaluated. Tests were associated to bacteriological analysis and classified into three groups: uninfected (negative culture), infected by minor pathogens and infected by major pathogens. Coagulase-negative Staphylococcus (32.4%), Micrococcus spp. (32.4%), Corynebacterium spp. (5.4%), and Bacillus spp. (1.4%) were the minor pathogens isolated, while Staphylococcus aureus (27%) and Escherichia coli (1.4%) were the major pathogens isolated. A good correlation was found between the CMT and SCC, which included inflammatory and epithelial cells (r = 0.64; P < 0.0001). SCC averages for the CMT scores shown in parentheses were 223 576 (0); 245,248 (1); 397,778 (2); 1,159,109 (3) and 2,460,833 (4) cells/ml. The correlation between SCC and the infectious status of udder halves was 0.58 (P < 0.0001). The relationship between SCC and CMT profiles and infectious status studied by a discriminant analysis showed, with an accuracy of 65%, three infectious status groups. SCC arithmetic means were 244,470 cells/ml for negative culture, 1,044,100 cells/ml for minor pathogens and 2,045,652 cells/ ml for major pathogens. With the exception of 1-year-old ewes, no significant differences were observed in SCC as affected by age or parity.

Eprinomectin (EPM) is a broad-spectrum endectocide compound approved for use in dairy cattle with a zero milk-withdrawal period, but has not been registered for use in lactating dairy sheep. The pattern of EPM excretion in milk was comparatively characterized following its pour-on administration (500 microg/kg) to lactating dairy sheep at two different stages of lactation. The relationship between milk excretion and plasma disposition kinetics of EPM was characterized. Residual EPM concentrations were assessed during cheese making (whey and curd) and ripening (cheese) by high-performance liquid chromatography and fluorescence detection. EPM was poorly distributed from the bloodstream to the mammary gland and low concentrations were excreted in milk. The level of milk production (early-mid and mid-late lactation) did not affect either the plasma-milk distribution or the pattern of residual concentrations in milk. During cheese making, the highest residual concentrations of EPM were measured in the curd, which increased during cheese ripening, reaching a maximum after 40 days. However, these residual concentrations were below the maximum residue limit of 20 ng/ml established for EPM in bovine's milk. Therefore, these dairy products could be considered safe for consumers after the EPM antiparasitic pour-on treatment (500 microg/kg) in lactating dairy sheep.